Catalog No.: PC-62342Not For Human Use, Lab Use Only.
Isobutyl-deoxynyboquinone (IB-DNQ) is a selective substrate for NAD(P)H:quinone oxidoreductase (NQO1), produces ROS, and induces cytotoxicity in cancer cells in an NQO1-dependent manner.
Isobutyl-deoxynyboquinone (IB-DNQ) is a selective substrate for NAD(P)H:quinone oxidoreductase (NQO1), produces ROS, and induces cytotoxicity in cancer cells in an NQO1-dependent manner.
IB-DNQ has improved solubility and biocompatibility in comparison with DNQ.
IB-DNQ is a superior drug candidate for evaluating anticancer activities and tolerability in vivo.
